Recovery of a triazole-resistant Aspergillus fumigatus in respiratory specimen of COVID-19 patient in ICU - A case report
- PMID: 32837880
- PMCID: PMC7331532
- DOI: 10.1016/j.mmcr.2020.06.006
Recovery of a triazole-resistant Aspergillus fumigatus in respiratory specimen of COVID-19 patient in ICU - A case report
Abstract
Although invasive pulmonary aspergillosis (IPA) is typically described in immunocompromised host, patient with severe influenzae can develop IPA. Similarly, patients with severe COVID-19 complicated with IPA are increasingly reported. Here, we describe a case of invasive aspergillosis with triazole-resistant A. fumigatus (TR34/L98H mutation) in a 56-year-old patient with COVID-19 in intensive care unit. This report highlights the need to define the available tools for diagnosis of invasive aspergillosis in severe COVID-19 patients.
Keywords: Aspergillosis; COVID-19; Coronavirus; ICU; SARS-CoV2; Triazole-resistance.
© 2020 The Authors.
Conflict of interest statement
There was no funding for this manuscript. All authors declare that they have no conflicts of interest regarding this manuscript.
Figures
Similar articles
-
Occurrence of triazole-resistant Aspergillus fumigatus with TR34/L98H mutations in outdoor and hospital environment in Kuwait.Environ Res. 2014 Aug;133:20-6. doi: 10.1016/j.envres.2014.05.009. Epub 2014 Jun 4. Environ Res. 2014. PMID: 24906064
-
Multidrug-Resistant Aspergillus fumigatus Carrying Mutations Linked to Environmental Fungicide Exposure - Three States, 2010-2017.MMWR Morb Mortal Wkly Rep. 2018 Sep 28;67(38):1064-1067. doi: 10.15585/mmwr.mm6738a5. MMWR Morb Mortal Wkly Rep. 2018. PMID: 30260939 Free PMC article.
-
Prevalence and mechanism of triazole resistance in Aspergillus fumigatus in a referral chest hospital in Delhi, India and an update of the situation in Asia.Front Microbiol. 2015 May 8;6:428. doi: 10.3389/fmicb.2015.00428. eCollection 2015. Front Microbiol. 2015. PMID: 26005442 Free PMC article.
-
Risk factors for invasive aspergillosis in ICU patients with COVID-19: current insights and new key elements.Ann Intensive Care. 2021 Sep 15;11(1):136. doi: 10.1186/s13613-021-00923-4. Ann Intensive Care. 2021. PMID: 34524562 Free PMC article. Review.
-
Emerging threat of triazole-resistant Aspergillus fumigatus.J Antimicrob Chemother. 2019 Apr 1;74(4):835-842. doi: 10.1093/jac/dky517. J Antimicrob Chemother. 2019. PMID: 30561652 Free PMC article. Review.
Cited by
-
COVID-19 Associated Invasive Pulmonary Aspergillosis: Diagnostic and Therapeutic Challenges.J Fungi (Basel). 2020 Jul 22;6(3):115. doi: 10.3390/jof6030115. J Fungi (Basel). 2020. PMID: 32707965 Free PMC article. Review.
-
COVID-19-Associated Pulmonary Aspergillosis (CAPA).J Intensive Med. 2021 Aug 7;1(2):71-80. doi: 10.1016/j.jointm.2021.07.001. eCollection 2021 Oct. J Intensive Med. 2021. PMID: 36785564 Free PMC article. Review.
-
Specific Zn(II)-binding site in the C-terminus of Aspf2, a zincophore from Aspergillus fumigatus.Metallomics. 2022 Jul 20;14(7):mfac042. doi: 10.1093/mtomcs/mfac042. Metallomics. 2022. PMID: 35700143 Free PMC article.
-
COVID-19-Associated Fungal Infections: An Urgent Need for Alternative Therapeutic Approach?Front Microbiol. 2022 Jun 9;13:919501. doi: 10.3389/fmicb.2022.919501. eCollection 2022. Front Microbiol. 2022. PMID: 35756020 Free PMC article. Review.
-
COVID-19-Associated Pulmonary Aspergillosis, Fungemia, and Pneumocystosis in the Intensive Care Unit: a Retrospective Multicenter Observational Cohort during the First French Pandemic Wave.Microbiol Spectr. 2021 Oct 31;9(2):e0113821. doi: 10.1128/Spectrum.01138-21. Epub 2021 Oct 20. Microbiol Spectr. 2021. PMID: 34668768 Free PMC article.
References
-
- Blot S.I., Taccone F.S., Van Den Abeele A.M., Bulpa P., Meersseman W., Brusselaers N. A clinical algorithm to diagnose invasive pulmonary aspergillosis in critically ill patients. Am. J. Respir. Crit. Care Med. 2012;186(1):56–64. - PubMed
-
- Donnelly J.P., Chen S.C., Kauffman C.A., Steinbach W.J., Baddley J.W., Verweij P.E. Revision and update of the consensus definitions of invasive fungal disease from the European organization for Research and treatment of cancer and the mycoses study Group education and Research Consortium. Clin. Infect. Dis. 2019;46 1813–10. - PMC - PubMed
-
- Schauwvlieghe A.F.A.D., Rijnders B.J.A., Philips N., Verwijs R., Vanderbeke L., Van Tienen C. Invasive aspergillosis in patients admitted to the intensive care unit with severe influenza: a retrospective cohort study. Lancet Respir. Med. 2018;6(10):782–792. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous